LABORATORY CORP OF AMERICA HOLDINGS
LH Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-06-03
2025-06-05
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
S - Sale
Common Stock
-2,000
$247.00
-494K
1
$21.88B
2025-05-01
2025-05-05
VAN DER VAART SANDRA
EVP, Chief Legal Officer
S - Sale
Common Stock
-1,900
$238.00
-452K
1
$21.88B
2025-05-01
2025-05-05
WILKINSON PETER
SVP, Chief Accounting Officer
S - Sale
Common Stock
-829
$242.00
-201K
1
$21.88B
2025-04-01
2025-04-03
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
M - Exercise
Common Stock
4,287
2
$21.88B
2025-04-01
2025-04-03
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
M - Exercise
Restricted Stock Unit
-4,287
$0.00
2
$21.88B
2025-04-01
2025-04-03
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
F - Tax
Common Stock
-1,614
$233.00
-376K
2
$21.88B
2025-03-28
2025-03-31
SUMMY AMY
EVP, Chief Marketing Officer
S - Sale
Common Stock
-758
$232.00
-176K
1
$21.88B
2025-03-28
2025-03-31
SCHROEDER MARK
EVP, Pres Diagnostics & COO
S - Sale
Common Stock
-2,635
$232.00
-611K
1
$21.88B
2025-03-27
2025-03-31
SCHROEDER MARK
EVP, Pres Diagnostics & COO
F - Tax
Common Stock
-2,205
$232.00
-512K
1
$21.88B
2025-03-27
2025-03-31
EISENBERG GLENN
Executive Vice President
A - Grant
Common Stock
8,305
$0.00
1
$21.88B
2025-03-27
2025-03-31
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
A - Grant
Common Stock
4,840
$0.00
1
$21.88B
2025-03-27
2025-03-31
VAN DER VAART SANDRA
EVP, Chief Legal Officer
A - Grant
Common Stock
3,325
$0.00
1
$21.88B
2025-03-27
2025-03-31
WILKINSON PETER
SVP, Chief Accounting Officer
A - Grant
Common Stock
1,249
$0.00
1
$21.88B
2025-03-27
2025-03-31
SCHROEDER MARK
EVP, Pres Diagnostics & COO
A - Grant
Common Stock
4,840
$0.00
1
$21.88B
2025-03-27
2025-03-31
BERBERIAN LANCE
EVP, Special Advisor, Strategy
A - Grant
Common Stock
3,325
$0.00
1
$21.88B
2025-03-27
2025-03-31
WILKINSON PETER
SVP, Chief Accounting Officer
F - Tax
Common Stock
-359
$232.00
-83,288
1
$21.88B
2025-03-27
2025-03-31
BERBERIAN LANCE
EVP, Special Advisor, Strategy
F - Tax
Common Stock
-1,353
$232.00
-314K
1
$21.88B
2025-03-27
2025-03-31
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
F - Tax
Common Stock
-2,109
$232.00
-489K
1
$21.88B
2025-03-27
2025-03-31
EISENBERG GLENN
Executive Vice President
F - Tax
Common Stock
-3,630
$232.00
-842K
1
$21.88B
2025-03-27
2025-03-31
OYEGUNWA AKINBOLADE
EVP, CIO & CTO
F - Tax
Common Stock
-198
$232.00
-45,936
1
$21.88B
2025-03-27
2025-03-31
VAN DER VAART SANDRA
EVP, Chief Legal Officer
F - Tax
Common Stock
-1,352
$232.00
-314K
1
$21.88B
2025-03-27
2025-03-31
SUMMY AMY
EVP, Chief Marketing Officer
F - Tax
Common Stock
-562
$232.00
-130K
1
$21.88B
2025-02-28
2025-03-04
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Common Stock
3,903
$131.00
511K
1
$21.88B
2025-02-28
2025-03-04
SCHROEDER MARK
EVP, Pres Diagnostics & COO
S - Sale
Common Stock
-5,339
$249.00
-1.33M
1
$21.88B
2025-02-28
2025-03-04
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Non-qualified Stock Options
-3,903
$0.00
1
$21.88B
2025-02-25
2025-02-27
VAN DER VAART SANDRA
EVP, Chief Legal Officer
S - Sale
Common Stock
-1,314
$251.00
-330K
1
$21.88B
2025-02-24
2025-02-26
SUMMY AMY
EVP, Chief Marketing Officer
S - Sale
Common Stock
-226
$250.00
-56,500
1
$21.88B
2025-02-18
2025-02-20
WILKINSON PETER
SVP, Chief Accounting Officer
S - Sale
Common Stock
-1,413
$246.00
-348K
1
$21.88B
2025-02-18
2025-02-20
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Non-qualified Stock Options
-1,413
$0.00
1
$21.88B
2025-02-18
2025-02-20
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Non-qualified Stock Options
-1,413
$0.00
1
$21.88B
2025-02-18
2025-02-20
WILKINSON PETER
SVP, Chief Accounting Officer
S - Sale
Common Stock
-1,413
$246.00
-348K
1
$21.88B
2025-02-18
2025-02-20
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Common Stock
1,413
$164.00
232K
1
$21.88B
2025-02-18
2025-02-20
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Common Stock
1,413
$164.00
232K
1
$21.88B
2022-08-01
2025-02-20
WILKINSON PETER
SVP, Chief Accounting Officer
G - Gift
Common Stock
-351
$0.00
1
$21.88B
2025-02-11
2025-02-13
SCHROEDER MARK
EVP, Pres Diagnostics & COO
A - Grant
Non-qualified Stock Options
7,300
$0.00
1
$21.88B
2025-02-11
2025-02-13
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Common Stock
123
1
$21.88B
2025-02-11
2025-02-13
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-123
$0.00
1
$21.88B
2025-02-11
2025-02-13
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Common Stock
323
1
$21.88B
2025-02-11
2025-02-13
WILKINSON PETER
SVP, Chief Accounting Officer
A - Grant
Non-qualified Stock Options
1,500
$0.00
1
$21.88B
2025-02-11
2025-02-13
WILKINSON PETER
SVP, Chief Accounting Officer
A - Grant
Restricted Stock Unit
2,090
$0.00
2
$21.88B
2025-02-11
2025-02-13
BERBERIAN LANCE
EVP, Special Advisor, Strategy
F - Tax
Common Stock
-86
$245.00
-21,070
1
$21.88B
2025-02-11
2025-02-13
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
F - Tax
Common Stock
-136
$245.00
-33,320
1
$21.88B
2025-02-11
2025-02-13
EISENBERG GLENN
Executive Vice President
F - Tax
Common Stock
-213
$245.00
-52,185
1
$21.88B
2025-02-11
2025-02-13
SCHROEDER MARK
EVP, Pres Diagnostics & COO
F - Tax
Common Stock
-134
$245.00
-32,830
1
$21.88B
2025-02-11
2025-02-13
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Restricted Stock Unit
-323
$0.00
1
$21.88B
2025-02-11
2025-02-13
SUMMY AMY
EVP, Chief Marketing Officer
M - Exercise
Restricted Stock Unit
-201
$0.00
1
$21.88B
2025-02-11
2025-02-13
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Restricted Stock Unit
-473
$0.00
1
$21.88B
2025-02-11
2025-02-13
SCHECHTER ADAM
President & CEO
M - Exercise
Restricted Stock Unit
-2,963
$0.00
1
$21.88B
2025-02-11
2025-02-13
OYEGUNWA AKINBOLADE
EVP, CIO & CTO
M - Exercise
Restricted Stock Unit
-134
$0.00
1
$21.88B
2025-02-11
2025-02-13
EISENBERG GLENN
Executive Vice President
M - Exercise
Restricted Stock Unit
-807
$0.00
1
$21.88B
2025-02-11
2025-02-13
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
M - Exercise
Restricted Stock Unit
-473
$0.00
1
$21.88B
2025-02-11
2025-02-13
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Common Stock
323
1
$21.88B
2025-02-11
2025-02-13
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Restricted Stock Unit
-323
$0.00
1
$21.88B
2025-02-11
2025-02-13
WILKINSON PETER
SVP, Chief Accounting Officer
F - Tax
Common Stock
-41
$245.00
-10,045
1
$21.88B
2025-02-11
2025-02-13
VAN DER VAART SANDRA
EVP, Chief Legal Officer
F - Tax
Common Stock
-86
$245.00
-21,070
1
$21.88B
2025-02-11
2025-02-13
SUMMY AMY
EVP, Chief Marketing Officer
F - Tax
Common Stock
-55
$245.00
-13,475
1
$21.88B
2025-02-11
2025-02-13
WANG JULIA AIJUN
Chief Financial Officer, EVP
A - Grant
Restricted Stock Unit
2,580
$0.00
1
$21.88B
2025-02-11
2025-02-13
WANG JULIA AIJUN
Chief Financial Officer, EVP
A - Grant
Non-qualified Stock Options
7,800
$0.00
1
$21.88B
2025-02-11
2025-02-13
VAN DER VAART SANDRA
EVP, Chief Legal Officer
A - Grant
Restricted Stock Unit
1,130
$0.00
1
$21.88B
2025-02-11
2025-02-13
VAN DER VAART SANDRA
EVP, Chief Legal Officer
A - Grant
Non-qualified Stock Options
3,400
$0.00
1
$21.88B
2025-02-11
2025-02-13
SUMMY AMY
EVP, Chief Marketing Officer
A - Grant
Restricted Stock Unit
690
$0.00
1
$21.88B
2025-02-11
2025-02-13
SUMMY AMY
EVP, Chief Marketing Officer
A - Grant
Non-qualified Stock Options
2,100
$0.00
1
$21.88B
2025-02-11
2025-02-13
SCHROEDER MARK
EVP, Pres Diagnostics & COO
A - Grant
Restricted Stock Unit
2,420
$0.00
1
$21.88B
2025-02-11
2025-02-13
SCHECHTER ADAM
President & CEO
A - Grant
Restricted Stock Unit
10,970
$0.00
1
$21.88B
2025-02-11
2025-02-13
SCHECHTER ADAM
President & CEO
A - Grant
Non-qualified Stock Options
33,100
$0.00
1
$21.88B
2025-02-11
2025-02-13
OYEGUNWA AKINBOLADE
EVP, CIO & CTO
A - Grant
Restricted Stock Unit
690
$0.00
1
$21.88B
2025-02-11
2025-02-13
OYEGUNWA AKINBOLADE
EVP, CIO & CTO
A - Grant
Non-qualified Stock Options
2,100
$0.00
1
$21.88B
2025-02-11
2025-02-13
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
A - Grant
Restricted Stock Unit
2,220
$0.00
1
$21.88B
2025-02-11
2025-02-13
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
A - Grant
Non-qualified Stock Options
6,700
$0.00
1
$21.88B
2025-02-11
2025-02-13
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
A - Grant
Restricted Stock Unit
1,210
$0.00
1
$21.88B
2025-02-11
2025-02-13
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
A - Grant
Non-qualified Stock Options
3,700
$0.00
1
$21.88B
2025-02-07
2025-02-10
SCHROEDER MARK
EVP, Pres Diagnostics & COO
F - Tax
Common Stock
-193
$246.00
-47,478
2
$21.88B
2025-02-07
2025-02-10
EISENBERG GLENN
Executive Vice President
F - Tax
Common Stock
-234
$246.00
-57,564
1
$21.88B
2025-02-07
2025-02-10
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
F - Tax
Common Stock
-182
$246.00
-44,772
2
$21.88B
2025-02-07
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
F - Tax
Common Stock
-94
$246.00
-23,124
1
$21.88B
2025-02-07
2025-02-10
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
F - Tax
Common Stock
-107
$246.00
-26,322
2
$21.88B
2025-02-07
2025-02-10
SCHROEDER MARK
EVP, Pres Diagnostics & COO
F - Tax
Common Stock
-193
$246.00
-47,478
2
$21.88B
2025-02-07
2025-02-10
SUMMY AMY
EVP, Chief Marketing Officer
F - Tax
Common Stock
-68
$246.00
-16,728
1
$21.88B
2025-02-07
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
F - Tax
Common Stock
-94
$246.00
-23,124
1
$21.88B
2025-02-07
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
F - Tax
Common Stock
-46
$246.00
-11,316
1
$21.88B
2025-02-07
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Common Stock
354
1
$21.88B
2025-02-07
2025-02-10
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
M - Exercise
Restricted Stock Unit
-291
$0.00
2
$21.88B
2025-02-07
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Common Stock
134
1
$21.88B
2025-02-07
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Restricted Stock Unit
-354
$0.00
1
$21.88B
2025-02-07
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-134
$0.00
1
$21.88B
2025-02-07
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Common Stock
354
1
$21.88B
2025-02-07
2025-02-10
EISENBERG GLENN
Executive Vice President
M - Exercise
Restricted Stock Unit
-885
$0.00
1
$21.88B
2025-02-07
2025-02-10
OYEGUNWA AKINBOLADE
EVP, CIO & CTO
M - Exercise
Restricted Stock Unit
-149
$0.00
1
$21.88B
2025-02-07
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Restricted Stock Unit
-354
$0.00
1
$21.88B
2025-02-07
2025-02-10
SCHECHTER ADAM
President & CEO
M - Exercise
Restricted Stock Unit
-3,250
$0.00
1
$21.88B
2025-02-07
2025-02-10
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Restricted Stock Unit
-681
$0.00
2
$21.88B
2025-02-07
2025-02-10
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
M - Exercise
Restricted Stock Unit
-629
$0.00
2
$21.88B
2025-02-07
2025-02-10
SUMMY AMY
EVP, Chief Marketing Officer
M - Exercise
Restricted Stock Unit
-224
$0.00
1
$21.88B
2025-02-07
2025-02-10
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
F - Tax
Common Stock
-107
$246.00
-26,322
2
$21.88B
2025-02-07
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
F - Tax
Common Stock
-94
$246.00
-23,124
1
$21.88B
2025-02-07
2025-02-10
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
F - Tax
Common Stock
-182
$246.00
-44,772
2
$21.88B
2025-02-07
2025-02-10
EISENBERG GLENN
Executive Vice President
F - Tax
Common Stock
-234
$246.00
-57,564
1
$21.88B
2025-02-07
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Common Stock
134
1
$21.88B
2025-02-07
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-134
$0.00
1
$21.88B
2025-02-07
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Common Stock
354
1
$21.88B
2025-02-07
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Restricted Stock Unit
-354
$0.00
1
$21.88B
2025-02-07
2025-02-10
SUMMY AMY
EVP, Chief Marketing Officer
M - Exercise
Restricted Stock Unit
-224
$0.00
1
$21.88B
2025-02-07
2025-02-10
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Restricted Stock Unit
-681
$0.00
2
$21.88B
2025-02-07
2025-02-10
SCHECHTER ADAM
President & CEO
M - Exercise
Restricted Stock Unit
-3,250
$0.00
1
$21.88B
2025-02-07
2025-02-10
OYEGUNWA AKINBOLADE
EVP, CIO & CTO
M - Exercise
Restricted Stock Unit
-149
$0.00
1
$21.88B
2025-02-07
2025-02-10
EISENBERG GLENN
Executive Vice President
M - Exercise
Restricted Stock Unit
-885
$0.00
1
$21.88B
2025-02-07
2025-02-10
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
M - Exercise
Restricted Stock Unit
-629
$0.00
2
$21.88B
2025-02-07
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Common Stock
354
1
$21.88B
2025-02-07
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Restricted Stock Unit
-354
$0.00
1
$21.88B
2025-02-07
2025-02-10
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
M - Exercise
Restricted Stock Unit
-291
$0.00
2
$21.88B
2025-02-07
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
F - Tax
Common Stock
-46
$246.00
-11,316
1
$21.88B
2025-02-07
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
F - Tax
Common Stock
-94
$246.00
-23,124
1
$21.88B
2025-02-07
2025-02-10
SUMMY AMY
EVP, Chief Marketing Officer
F - Tax
Common Stock
-68
$246.00
-16,728
1
$21.88B
2025-02-06
2025-02-10
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
F - Tax
Common Stock
-70
$248.00
-17,360
1
$21.88B
2025-02-06
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Common Stock
133
1
$21.88B
2025-02-06
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-133
$0.00
1
$21.88B
2025-02-06
2025-02-10
WANG JULIA AIJUN
Chief Financial Officer, EVP
M - Exercise
Common Stock
893
1
$21.88B
2025-02-06
2025-02-10
WANG JULIA AIJUN
Chief Financial Officer, EVP
M - Exercise
Restricted Stock Unit
-893
$0.00
1
$21.88B
2025-02-06
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Common Stock
386
1
$21.88B
2025-02-06
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Restricted Stock Unit
-386
$0.00
1
$21.88B
2025-02-06
2025-02-10
SUMMY AMY
EVP, Chief Marketing Officer
M - Exercise
Restricted Stock Unit
-223
$0.00
1
$21.88B
2025-02-06
2025-02-10
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Restricted Stock Unit
-743
$0.00
1
$21.88B
2025-02-06
2025-02-10
SCHECHTER ADAM
President & CEO
M - Exercise
Restricted Stock Unit
-4,460
$0.00
1
$21.88B
2025-02-06
2025-02-10
OYEGUNWA AKINBOLADE
EVP, CIO & CTO
M - Exercise
Restricted Stock Unit
-180
$0.00
1
$21.88B
2025-02-06
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Common Stock
133
1
$21.88B
2025-02-06
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-133
$0.00
1
$21.88B
2025-02-06
2025-02-10
WANG JULIA AIJUN
Chief Financial Officer, EVP
M - Exercise
Common Stock
893
1
$21.88B
2025-02-06
2025-02-10
WANG JULIA AIJUN
Chief Financial Officer, EVP
M - Exercise
Restricted Stock Unit
-893
$0.00
1
$21.88B
2025-02-06
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Common Stock
386
1
$21.88B
2025-02-06
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Restricted Stock Unit
-386
$0.00
1
$21.88B
2025-02-06
2025-02-10
SUMMY AMY
EVP, Chief Marketing Officer
M - Exercise
Restricted Stock Unit
-223
$0.00
1
$21.88B
2025-02-06
2025-02-10
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Restricted Stock Unit
-743
$0.00
1
$21.88B
2025-02-06
2025-02-10
SCHECHTER ADAM
President & CEO
M - Exercise
Restricted Stock Unit
-4,460
$0.00
1
$21.88B
2025-02-06
2025-02-10
OYEGUNWA AKINBOLADE
EVP, CIO & CTO
M - Exercise
Restricted Stock Unit
-180
$0.00
1
$21.88B
2025-02-06
2025-02-10
EISENBERG GLENN
Executive Vice President
M - Exercise
Restricted Stock Unit
-966
$0.00
1
$21.88B
2025-02-06
2025-02-10
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
M - Exercise
Restricted Stock Unit
-670
$0.00
1
$21.88B
2025-02-06
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Common Stock
356
1
$21.88B
2025-02-06
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Restricted Stock Unit
-356
$0.00
1
$21.88B
2025-02-06
2025-02-10
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
M - Exercise
Restricted Stock Unit
-180
$0.00
1
$21.88B
2025-02-06
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
F - Tax
Common Stock
-46
$248.00
-11,408
1
$21.88B
2025-02-06
2025-02-10
WANG JULIA AIJUN
Chief Financial Officer, EVP
F - Tax
Common Stock
-336
$248.00
-83,328
1
$21.88B
2025-02-06
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
F - Tax
Common Stock
-102
$248.00
-25,296
1
$21.88B
2025-02-06
2025-02-10
SUMMY AMY
EVP, Chief Marketing Officer
F - Tax
Common Stock
-73
$248.00
-18,104
1
$21.88B
2025-02-06
2025-02-10
SCHROEDER MARK
EVP, Pres Diagnostics & COO
F - Tax
Common Stock
-210
$248.00
-52,080
1
$21.88B
2025-02-06
2025-02-10
EISENBERG GLENN
Executive Vice President
F - Tax
Common Stock
-255
$248.00
-63,240
1
$21.88B
2025-02-06
2025-02-10
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
F - Tax
Common Stock
-212
$248.00
-52,576
1
$21.88B
2025-02-06
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
F - Tax
Common Stock
-94
$248.00
-23,312
1
$21.88B
2025-02-06
2025-02-10
EISENBERG GLENN
Executive Vice President
M - Exercise
Restricted Stock Unit
-966
$0.00
1
$21.88B
2025-02-06
2025-02-10
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
M - Exercise
Restricted Stock Unit
-670
$0.00
1
$21.88B
2025-02-06
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Common Stock
356
1
$21.88B
2025-02-06
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Restricted Stock Unit
-356
$0.00
1
$21.88B
2025-02-06
2025-02-10
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
M - Exercise
Restricted Stock Unit
-180
$0.00
1
$21.88B
2025-02-06
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
F - Tax
Common Stock
-46
$248.00
-11,408
1
$21.88B
2025-02-06
2025-02-10
WANG JULIA AIJUN
Chief Financial Officer, EVP
F - Tax
Common Stock
-336
$248.00
-83,328
1
$21.88B
2025-02-06
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
F - Tax
Common Stock
-102
$248.00
-25,296
1
$21.88B
2025-02-06
2025-02-10
SUMMY AMY
EVP, Chief Marketing Officer
F - Tax
Common Stock
-73
$248.00
-18,104
1
$21.88B
2025-02-06
2025-02-10
SCHROEDER MARK
EVP, Pres Diagnostics & COO
F - Tax
Common Stock
-210
$248.00
-52,080
1
$21.88B
2025-02-06
2025-02-10
EISENBERG GLENN
Executive Vice President
F - Tax
Common Stock
-255
$248.00
-63,240
1
$21.88B
2025-02-06
2025-02-10
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
F - Tax
Common Stock
-212
$248.00
-52,576
1
$21.88B
2025-02-06
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
F - Tax
Common Stock
-94
$248.00
-23,312
1
$21.88B
2025-02-06
2025-02-10
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
F - Tax
Common Stock
-70
$248.00
-17,360
1
$21.88B
2025-02-06
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Common Stock
133
1
$21.88B
2025-02-06
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-133
$0.00
1
$21.88B
2025-02-06
2025-02-10
WANG JULIA AIJUN
Chief Financial Officer, EVP
M - Exercise
Common Stock
893
1
$21.88B
2025-02-06
2025-02-10
WANG JULIA AIJUN
Chief Financial Officer, EVP
M - Exercise
Restricted Stock Unit
-893
$0.00
1
$21.88B
2025-02-06
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Common Stock
386
1
$21.88B
2025-02-06
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Restricted Stock Unit
-386
$0.00
1
$21.88B
2025-02-06
2025-02-10
SUMMY AMY
EVP, Chief Marketing Officer
M - Exercise
Restricted Stock Unit
-223
$0.00
1
$21.88B
2025-02-06
2025-02-10
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Restricted Stock Unit
-743
$0.00
1
$21.88B
2025-02-06
2025-02-10
SCHECHTER ADAM
President & CEO
M - Exercise
Restricted Stock Unit
-4,460
$0.00
1
$21.88B
2025-02-06
2025-02-10
OYEGUNWA AKINBOLADE
EVP, CIO & CTO
M - Exercise
Restricted Stock Unit
-180
$0.00
1
$21.88B
2025-02-06
2025-02-10
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
F - Tax
Common Stock
-70
$248.00
-17,360
1
$21.88B
2025-02-06
2025-02-10
EISENBERG GLENN
Executive Vice President
M - Exercise
Restricted Stock Unit
-966
$0.00
1
$21.88B
2025-02-06
2025-02-10
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
M - Exercise
Restricted Stock Unit
-670
$0.00
1
$21.88B
2025-02-06
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Common Stock
356
1
$21.88B
2025-02-06
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
M - Exercise
Restricted Stock Unit
-356
$0.00
1
$21.88B
2025-02-06
2025-02-10
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
M - Exercise
Restricted Stock Unit
-180
$0.00
1
$21.88B
2025-02-06
2025-02-10
WILKINSON PETER
SVP, Chief Accounting Officer
F - Tax
Common Stock
-46
$248.00
-11,408
1
$21.88B
2025-02-06
2025-02-10
WANG JULIA AIJUN
Chief Financial Officer, EVP
F - Tax
Common Stock
-336
$248.00
-83,328
1
$21.88B
2025-02-06
2025-02-10
SUMMY AMY
EVP, Chief Marketing Officer
F - Tax
Common Stock
-73
$248.00
-18,104
1
$21.88B
2025-02-06
2025-02-10
SCHROEDER MARK
EVP, Pres Diagnostics & COO
F - Tax
Common Stock
-210
$248.00
-52,080
1
$21.88B
2025-02-06
2025-02-10
EISENBERG GLENN
Executive Vice President
F - Tax
Common Stock
-255
$248.00
-63,240
1
$21.88B
2025-02-06
2025-02-10
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
F - Tax
Common Stock
-212
$248.00
-52,576
1
$21.88B
2025-02-06
2025-02-10
BERBERIAN LANCE
EVP, Special Advisor, Strategy
F - Tax
Common Stock
-94
$248.00
-23,312
1
$21.88B
2025-02-06
2025-02-10
VAN DER VAART SANDRA
EVP, Chief Legal Officer
F - Tax
Common Stock
-102
$248.00
-25,296
1
$21.88B
2024-12-02
2024-12-04
WANG JULIA AIJUN
Chief Financial Officer, EVP
A - Grant
Restricted Stock Unit
2,680
$0.00
1
$21.88B
2024-12-02
2024-12-04
EISENBERG GLENN
Executive Vice President
M - Exercise
Non-qualified Stock Options
-11,711
$0.00
2
$21.88B
2024-12-02
2024-12-04
EISENBERG GLENN
Executive Vice President
M - Exercise
Common Stock
11,711
$212.00
2.48M
2
$21.88B
2024-12-02
2024-12-04
EISENBERG GLENN
Executive Vice President
S - Sale
Common Stock
-11,711
$240.00
-2.81M
1
$21.88B
2024-12-02
2024-12-04
WANG JULIA AIJUN
Chief Financial Officer, EVP
A - Grant
Non-qualified Stock Options
8,100
$0.00
1
$21.88B
2024-11-22
2024-11-26
SUMMY AMY
EVP, Chief Marketing Officer
S - Sale
Common Stock
-3,671
$239.00
-877K
1
$21.88B
2024-11-22
2024-11-26
SUMMY AMY
EVP, Chief Marketing Officer
M - Exercise
Common Stock
4,015
$169.00
679K
1
$21.88B
2024-11-22
2024-11-26
SUMMY AMY
EVP, Chief Marketing Officer
M - Exercise
Non-qualified Stock Options
-4,015
$0.00
1
$21.88B
2024-11-21
2024-11-25
VAN DER VAART SANDRA
EVP, Chief Legal Officer
S - Sale
Common Stock
-1,000
$239.00
-239K
1
$21.88B
2024-11-01
2024-11-05
OYEGUNWA AKINBOLADE
EVP, CIO & CTO
A - Grant
Restricted Stock Unit
1,110
$0.00
1
$21.88B
2024-11-01
2024-11-05
BAILEY MEGAN
EVP, Pres, Central Labs & Intl
A - Grant
Restricted Stock Unit
1,110
$0.00
1
$21.88B
2024-09-03
2024-09-03
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
S - Sale
-5,460
$230.00
-1.26M
1
$21.88B
2024-09-03
2024-09-03
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
S - Sale
-5,461
$230.00
-1.26M
1
$21.88B
2024-08-19
2024-08-21
VAN DER VAART SANDRA
EVP, Chief Legal Officer
S - Sale
Common Stock
-2,000
$227.00
-454K
1
$21.88B
2024-08-15
2024-08-19
EISENBERG GLENN
Chief Financial Officer, EVP
S - Sale
Common Stock
-15,000
$224.00
-3.36M
3
$21.88B
2024-05-14
2024-05-16
VAN DER VAART SANDRA
EVP, Chief Legal Officer
S - Sale
Common Stock
-2,000
$211.00
-422K
2
$21.88B
2024-04-30
2024-05-02
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Performance Share Unit
-10,229
1
$21.88B
2024-04-30
2024-05-02
EISENBERG GLENN
Chief Financial Officer, EVP
F - Tax
Common Stock
-4,496
$201.00
-904K
1
$21.88B
2024-04-30
2024-05-02
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Common Stock
10,229
1
$21.88B
2024-04-29
2024-05-01
WILKINSON PETER
SVP, Chief Accounting Officer
S - Sale
Common Stock
-2,439
$204.00
-498K
1
$21.88B
2024-04-15
2024-04-17
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Common Stock
10,229
1
$21.88B
2024-04-15
2024-04-17
EISENBERG GLENN
Chief Financial Officer, EVP
F - Tax
Common Stock
-4,496
$203.00
-913K
1
$21.88B
2024-04-15
2024-04-17
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Restricted Stock Unit
-10,229
$0.00
1
$21.88B
2024-04-01
2024-04-03
BAILEY MEGAN
EVP, Chief Strategy Officer
M - Exercise
Restricted Stock Unit
-205
$0.00
1
$21.88B
2024-04-01
2024-04-03
BAILEY MEGAN
EVP, Chief Strategy Officer
F - Tax
Common Stock
-69
$216.00
-14,904
1
$21.88B
2024-04-01
2024-04-03
SUMMY AMY
EVP, Chief Marketing Officer
S - Sale
Common Stock
-3,500
$217.00
-760K
1
$21.88B
2024-04-01
2024-04-03
SCHROEDER MARK
EVP, Pres Diagnostics & COO
S - Sale
Common Stock
-6,477
$217.00
-1.41M
1
$21.88B
2024-03-28
2024-03-29
VAN DER VAART SANDRA
EVP, Chief Legal Officer
S - Sale
Common Stock
-3,553
$217.00
-771K
1
$21.88B
2024-03-27
2024-03-29
SCHECHTER ADAM
President and CEO
F - Tax
Common Stock
-31,799
$217.00
-6.90M
1
$21.88B
2024-03-27
2024-03-29
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
F - Tax
Common Stock
-952
$217.00
-207K
1
$21.88B
2024-03-27
2024-03-29
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
F - Tax
Common Stock
-5,061
$217.00
-1.10M
1
$21.88B
2024-03-27
2024-03-29
SUMMY AMY
EVP, Chief Marketing Officer
M - Exercise
Restricted Stock Unit
-5,778
1
$21.88B
2024-03-27
2024-03-29
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Common Stock
11,556
1
$21.88B
2024-03-27
2024-03-29
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Restricted Stock Unit
-11,556
1
$21.88B
2024-03-27
2024-03-29
SCHECHTER ADAM
President and CEO
M - Exercise
Restricted Stock Unit
-72,435
1
$21.88B
2024-03-27
2024-03-29
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Common Stock
20,033
1
$21.88B
2024-03-27
2024-03-29
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Restricted Stock Unit
-20,033
1
$21.88B
2024-03-27
2024-03-29
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
M - Exercise
Common Stock
3,012
1
$21.88B
2024-03-27
2024-03-29
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
M - Exercise
Restricted Stock Unit
-3,012
1
$21.88B
2024-03-27
2024-03-29
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
M - Exercise
Restricted Stock Unit
-11,556
1
$21.88B
2024-03-27
2024-03-29
WILKINSON PETER
SVP, Chief Accounting Officer
F - Tax
Common Stock
-894
$217.00
-194K
1
$21.88B
2024-03-27
2024-03-29
VAN DER VAART SANDRA
EVP, Chief Legal Officer
F - Tax
Common Stock
-2,605
$217.00
-565K
1
$21.88B
2024-03-27
2024-03-29
SUMMY AMY
EVP, Chief Marketing Officer
F - Tax
Common Stock
-2,162
$217.00
-469K
1
$21.88B
2024-03-27
2024-03-29
SCHROEDER MARK
EVP, Pres Diagnostics & COO
F - Tax
Common Stock
-5,079
$217.00
-1.10M
1
$21.88B
2024-03-27
2024-03-29
EISENBERG GLENN
Chief Financial Officer, EVP
F - Tax
Common Stock
-8,805
$217.00
-1.91M
1
$21.88B
2024-03-27
2024-03-29
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Common Stock
3,079
1
$21.88B
2024-03-27
2024-03-29
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-3,079
1
$21.88B
2024-03-27
2024-03-29
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Common Stock
6,158
1
$21.88B
2024-03-27
2024-03-29
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Restricted Stock Unit
-6,158
1
$21.88B
2024-03-07
2024-03-11
SUMMY AMY
EVP, Chief Marketing Officer
S - Sale
Common Stock
-227
$218.00
-49,486
1
$21.88B
2024-03-07
2024-03-11
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Non-qualified Stock Options
-2,119
$0.00
1
$21.88B
2024-03-07
2024-03-11
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Common Stock
2,119
$117.00
248K
1
$21.88B
2024-03-07
2024-03-11
SCHROEDER MARK
EVP, Pres Diagnostics & COO
S - Sale
Common Stock
-5,048
$218.00
-1.10M
1
$21.88B
2024-02-21
2024-02-22
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
S - Sale
Common Stock
-500
$215.00
-108K
1
$21.88B
2024-02-21
2024-02-22
EISENBERG GLENN
Chief Financial Officer, EVP
S - Sale
Common Stock
-34,504
$216.00
-7.45M
4
$21.88B
2024-02-21
2024-02-22
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Non-qualified Stock Options
-14,054
$0.00
1
$21.88B
2024-02-21
2024-02-22
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Common Stock
14,054
$164.00
2.30M
1
$21.88B
2024-02-13
2024-02-15
VAN DER VAART SANDRA
EVP, Chief Legal Officer
S - Sale
Common Stock
-237
$226.00
-53,562
1
$21.88B
2024-02-12
2024-02-13
SCHROEDER MARK
EVP, Pres Diagnostics & COO
F - Tax
Common Stock
-126
$227.00
-28,602
1
$21.88B
2024-02-12
2024-02-13
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
F - Tax
Common Stock
-137
$227.00
-31,099
1
$21.88B
2024-02-12
2024-02-13
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
F - Tax
Common Stock
-59
$227.00
-13,393
1
$21.88B
2024-02-12
2024-02-13
EISENBERG GLENN
Chief Financial Officer, EVP
F - Tax
Common Stock
-215
$227.00
-48,805
1
$21.88B
2024-02-12
2024-02-13
SUMMY AMY
EVP, Chief Marketing Officer
F - Tax
Common Stock
-66
$227.00
-14,982
1
$21.88B
2024-02-12
2024-02-13
VAN DER VAART SANDRA
EVP, Chief Legal Officer
F - Tax
Common Stock
-87
$227.00
-19,749
1
$21.88B
2024-02-12
2024-02-13
WILKINSON PETER
SVP, Chief Accounting Officer
F - Tax
Common Stock
-43
$227.00
-9,761
1
$21.88B
2024-02-11
2024-02-13
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Common Stock
807
1
$21.88B
2024-02-11
2024-02-13
BERBERIAN LANCE
EVP, CIO & CTO
M - Exercise
Restricted Stock Unit
-324
$0.00
1
$21.88B
2024-02-11
2024-02-13
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
M - Exercise
Restricted Stock Unit
-472
$0.00
1
$21.88B
2024-02-11
2024-02-13
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
M - Exercise
Restricted Stock Unit
-201
$0.00
1
$21.88B
2024-02-11
2024-02-13
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
M - Exercise
Common Stock
201
1
$21.88B
2024-02-11
2024-02-13
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Restricted Stock Unit
-807
$0.00
1
$21.88B
2024-02-11
2024-02-13
SCHECHTER ADAM
President & CEO
M - Exercise
Restricted Stock Unit
-2,964
$0.00
1
$21.88B
2024-02-11
2024-02-13
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Restricted Stock Unit
-472
$0.00
1
$21.88B
2024-02-11
2024-02-13
SUMMY AMY
EVP, Chief Marketing Officer
M - Exercise
Restricted Stock Unit
-201
$0.00
1
$21.88B
2024-02-11
2024-02-13
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Restricted Stock Unit
-324
$0.00
1
$21.88B
2024-02-11
2024-02-13
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Common Stock
324
1
$21.88B
2024-02-11
2024-02-13
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-123
$0.00
1
$21.88B
2024-02-11
2024-02-13
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Common Stock
123
1
$21.88B
2024-02-08
2024-02-09
VAN DER VAART SANDRA
EVP, Chief Legal Officer
S - Sale
Common Stock
-259
$222.00
-57,498
1
$21.88B
2024-02-07
2024-02-08
BAILEY MEGAN
EVP, Chief Strategy Officer
F - Tax
Common Stock
-113
$224.00
-25,312
2
$21.88B
2024-02-07
2024-02-08
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Common Stock
134
1
$21.88B
2024-02-07
2024-02-08
WILKINSON PETER
SVP, Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-134
$0.00
1
$21.88B
2024-02-07
2024-02-08
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Common Stock
353
1
$21.88B
2024-02-07
2024-02-08
VAN DER VAART SANDRA
EVP, Chief Legal Officer
M - Exercise
Restricted Stock Unit
-353
$0.00
1
$21.88B
2024-02-07
2024-02-08
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Common Stock
885
1
$21.88B
2024-02-07
2024-02-08
EISENBERG GLENN
Chief Financial Officer, EVP
M - Exercise
Restricted Stock Unit
-885
$0.00
1
$21.88B
2024-02-07
2024-02-08
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
M - Exercise
Common Stock
362
2
$21.88B
2024-02-07
2024-02-08
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
M - Exercise
Restricted Stock Unit
-362
$0.00
2
$21.88B
2024-02-07
2024-02-08
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
M - Exercise
Restricted Stock Unit
-629
$0.00
2
$21.88B
2024-02-07
2024-02-08
BERBERIAN LANCE
EVP, CIO & CTO
M - Exercise
Restricted Stock Unit
-353
$0.00
1
$21.88B
2024-02-07
2024-02-08
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
F - Tax
Common Stock
-204
$224.00
-45,696
2
$21.88B
2024-02-07
2024-02-08
DIVINCENZO JONATHAN
EVP, Pres, Central Labs & Intl
F - Tax
Common Stock
-119
$224.00
-26,656
2
$21.88B
2024-02-07
2024-02-08
EISENBERG GLENN
Chief Financial Officer, EVP
F - Tax
Common Stock
-236
$224.00
-52,864
1
$21.88B
2024-02-07
2024-02-08
SCHECHTER ADAM
President & CEO
M - Exercise
Restricted Stock Unit
-3,250
$0.00
1
$21.88B
2024-02-07
2024-02-08
SCHROEDER MARK
EVP, Pres Diagnostics & COO
M - Exercise
Restricted Stock Unit
-680
$0.00
2
$21.88B
2024-02-07
2024-02-08
SUMMY AMY
EVP, Chief Marketing Officer
M - Exercise
Restricted Stock Unit
-224
$0.00
1
$21.88B
2024-02-07
2024-02-08
BAILEY MEGAN
EVP, Chief Strategy Officer
M - Exercise
Restricted Stock Unit
-291
$0.00
2
$21.88B
2024-02-07
2024-02-08
WILKINSON PETER
SVP, Chief Accounting Officer
F - Tax
Common Stock
-46
$224.00
-10,304
1
$21.88B
2024-02-07
2024-02-08
VAN DER VAART SANDRA
EVP, Chief Legal Officer
F - Tax
Common Stock
-94
$224.00
-21,056
1
$21.88B
2024-02-07
2024-02-08
SUMMY AMY
EVP, Chief Marketing Officer
F - Tax
Common Stock
-73
$224.00
-16,352
1
$21.88B
2024-02-07
2024-02-08
SCHROEDER MARK
EVP, Pres Diagnostics & COO
F - Tax
Common Stock
-182
$224.00
-40,768
2
$21.88B
2024-02-06
2024-02-08
WILKINSON PETER
SVP, Chief Accounting Officer
A - Grant
Non-qualified Stock Options
1,200
$0.00
1
$21.88B
2024-02-06
2024-02-08
BAILEY MEGAN
EVP, Chief Strategy Officer
A - Grant
Non-qualified Stock Options
1,700
$0.00
1
$21.88B
2024-02-06
2024-02-08
BAILEY MEGAN
EVP, Chief Strategy Officer
A - Grant
Restricted Stock Unit
540
$0.00
1
$21.88B
2024-02-06
2024-02-08
BERBERIAN LANCE
EVP, CIO & CTO
A - Grant
Non-qualified Stock Options
3,300
$0.00
1
$21.88B
2024-02-06
2024-02-08
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
A - Grant
Non-qualified Stock Options
6,200
$0.00
1
$21.88B
2024-02-06
2024-02-08
CAVENEY BRIAN
EVP, Pres of ED, CMO & CSO
A - Grant
Restricted Stock Unit
2,010
$0.00
1
$21.88B